O. Bozdag-dundar et al., 3-ethyl-5-(5,6,7,8-tetrahydro-5,5,8,8-tetra-methyl-2-naphthylmethylene)thiazolidine-2,4-dione, ACT CRYST C, 55, 1999, pp. 1027-1029
The title compound, C20H25NO2S, is under investigation for potential retino
id-receptor activity. The molecular conformation is approximately planar, w
ith five methyl groups projecting from the mean plane. Twofold disorder of
the methylene groups of the tetrahydrotetramethyl residue was detected and
satisfactorily modelled.